Report Company Directory
- China Healthcare: Bi-Weekly: Affected By Geopolitical Headwinds by UOB
- Regional Morning Meeting Notes: Tuesday, September 09, 2025 by UOB
- WuXi Biologics (Cayman) (2269 HK): 1H25: Results satisfactory, guided higher revenue growth of 14-16% yoy in 2025. by UOB
- Greater China Daily: Thursday, August 21, 2025 by UOB
- Regional Morning Meeting Notes: Thursday, August 21, 2025 by UOB
- Regional Morning Meeting Notes: Thursday, July 31, 2025 by UOB
- China Healthcare Bi-Weekly: Expecting strong 1H25 results. Maintain OVERWEIGHT. by UOB
- China Healthcare Bi-weekly: Gaining strength on robust earnings outlook and pipeline growth. Maintain OVERWEIGHT. by UOB
- Regional Morning Meeting Notes: Wednesday, July 16, 2025 by UOB
- Regional Morning Meeting Notes: Thursday, June 19, 2025 by UOB